The role of genetically engineered biological agents and proinflammatory cytokines in the pathogenetic mechanisms of the Coronavirus infection (COVID-19).

KS Rutskaya-Moroshan, ST Abisheva, TV Vinnik… - 2023 - cabidigitallibrary.org
Relevance: The similarity of the pathogenetic mechanisms of coronavirus infection (COVID-
19) with autoimmune processes determinared the widespread use of genetically engineered …

APPLICATION OF GENE ENGINEERING IN THE TREATMENT OF PATIENTS WITH COVID-19

VD Moskaliuk, IV Balaniuk, SR Melenko… - Medical Science of …, 2024 - msu-journal.com
Background. Modern therapeutic options for the treatment of COVID-19 combine the use of
drugs that affect both the virus itself and the components of the body's immune response …

Pathogenetic therapy in case of COVID-19: decreasing of key hyper inflammatory response factors production

SV Nikolaeva - Therapy, 2023 - journals.eco-vector.com
Novel coronavirus infection has led to high morbidity and mortality throughout the whole
world. There are several genovariants of the SARS-CoV-2 virus, including Delta (B. 1.617. 2) …

[HTML][HTML] COVID-19: Observations on standard treatment algorithms

BI Kh, AZ Kh, TF Kh, MM Yusupova - Медицинская иммунология, 2021 - cyberleninka.ru
In this article, a retrospective analysis of the medical histories was carried out in order to
develop an individualized approach to treating COVID-19. Questions were raised about the …

Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region …

MA Korolev, EA Letyagina, AE Sizikov… - Terapevticheskii …, 2022 - ter-arkhiv.ru
Background. Currently, observations are accumulating indicating the negative effect of
therapy with a number of biologic disease-modifying anti-rheumatic drugs (bDMARDs) …

Biological Therapy During COVID-19

LS Namazova-Baranova, NN Murashkin… - Current …, 2020 - vsp.spr-journal.ru
There is crucial question on further therapeutic tactics for the management of such patients
(within the severe epidemiological situation caused by the pandemic of new coronavirus …

Application of monoclonal antibody drugs in treatment of COVID-19: a review

A Kirillova, A Lado, N Blatt - Bionanoscience, 2022 - Springer
Coronavirus infection can have various degrees of severity and outcomes. In some cases, it
causes excessive production of pro-inflammatory cytokines, a so-called cytokine storm …

Genetic predisposition and inflammatory inhibitors in COVID-19: where do we Stand?

M Sagris, P Theofilis, AS Antonopoulos, E Oikonomou… - Biomedicines, 2022 - mdpi.com
Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and the resulting
coronavirus disease-19 (COVID-19) have led to a global pandemic associated with high …

[HTML][HTML] COVID-19: аn Update on the Modern Etiotropic Therapy Methods for the New Coronavirus Infection

EA Sinitsyn, EV Smolyakova… - Journal of Clinical …, 2023 - journals.eco-vector.com
The COVID-19 pandemic, caused by the SARS-CoV-2 RNA-virus, has a significant impact
not only on the people's lifestyle and health, but on the global economy, as well. According …

Antiviral system of innate immunity: COVID-19 pathogenesis and treatment

AN Kazimirskii, JM Salmasi… - Bulletin of Russian State …, 2020 - cyberleninka.ru
Antiviral system of innate immunity includes two main components: the mitochondrial
antiviral sensor—the mitochondrial outer membrane protein and peripheral blood …